State of New Jersey Common Pension Fund D’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$557K Buy
151,892
+464
+0.3% +$1.54K ﹤0.01% 1622
2026
Q1
$465K Buy
151,428
+26,760
+21% +$103K ﹤0.01% 1465
2025
Q4
$510K Buy
+124,668
New +$617K ﹤0.01% 1446
2024
Q2
Sell
-188,897
Closed -$1.88M 1580
2024
Q1
$1.88M Buy
+188,897
New +$2.1M 0.01% 1515

Other funds holding RXRX

State of New Jersey Common Pension Fund D's RXRX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D increased its Recursion Pharmaceuticals (RXRX) stake by 0.31% in Q2 2026, buying an estimated $1.54K and bringing the position to 151,892 shares worth $557K. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

State of New Jersey Common Pension Fund D first reported a position in RXRX in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.88M in Q1 2024. 155 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 151,892 shares of Recursion Pharmaceuticals worth $557K as of Q2 2026.
  • State of New Jersey Common Pension Fund D bought 464 Recursion Pharmaceuticals shares in Q2 2026, an estimated $1.54K.
  • Recursion Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1622 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Recursion Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • State of New Jersey Common Pension Fund D's Recursion Pharmaceuticals position peaked at $1.88M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.